Natus Medical (Natus Medical) Total Stockholders Equity : $430.9 Mil (As of Mar. 2022)

View and export this data going back to 2001. Start your Free Trial

What is Natus Medical Total Stockholders Equity?

Natus Medical's Total Stockholders Equity for the quarter that ended in Mar. 2022 was $430.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Natus Medical's Book Value per Share for the quarter that ended in Mar. 2022 was $12.46. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Natus Medical's Debt-to-Equity for the quarter that ended in Mar. 2022 was 0.02.

Natus Medical Total Stockholders Equity Historical Data

The historical data trend for Natus Medical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natus Medical Total Stockholders Equity Chart

Natus Medical Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Stockholders Equity

Get a 7-Day Free Trial

422.10

398.44

416.12

411.09

424.75

Natus Medical Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Total Stockholders Equity	Get a 7-Day Free Trial															408.93	417.83	422.52	424.75	430.89

Natus Medical (NAS:NTUS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Natus Medical's Book Value per Share for the quarter that ended in Mar. 2022 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(430.894	-	0)	/	34.5761
	=	12.46

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Natus Medical's Debt-to-Equity for the quarter that ended in Mar. 2022 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.482	+	5.755)	/	430.894
	=	0.02

Natus Medical Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Natus Medical's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Natus Medical (Natus Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Natus Medical Inc (NAS:NTUS) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

3150 Pleasant View Road, Middleton, WI, USA, 53562

Website

https://www.natus.com

Natus Medical Inc is a provider of newborn care, neurology, and hearing and balance assessment healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. It is divided into three business units: Neuro, Newborn Care, and Hearing and Balance. The company generates a majority of its revenue from the Neurology business unit which includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care, and neurosurgery.

Executives

Chung Dong Chune Christopher	officer: Vice President Medical Affairs	1501 INDUSTRIAL ROAD SAN CARLOS CA 94070
Bryant M Moore	director	181 HARVEST LANE PITTSBORO NC 27312
Eric Guerin	director	1950 HASSELL ROAD, HOFFMAN ESTATES IL 60169
Ilan Daskal	director	1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Alice D. Schroeder	director	1573 MALLORY LANE, SUITE 100, BRENTWOOD TN 37027
Lisa Wipperman Heine	director	1244 76TH STREET WEST, INVER GROVE HEIGHTS MN 55077
Jonathan Kennedy	director, officer: Sr. VP, CFO	INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035
Ken Ludlum	director
Robert A Gunst	director
Noll Austin Francis Iii	officer: VP/GM Neurology	9805 FALLEN LEAF DRIVE MIDDLETON WI 53562
Thomas Joseph Sullivan	director	64 PETTIT PL PRINCETON NJ 08540
Benjamin Drew Davies	officer: Sr. VP, CFO	1501 INDUSTRIAL ROAD, SAN CARLOS X1 94070
Joshua Levine	director	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Sharon Villaverde	officer: Interim CFO	11780 U.S. HIGHWAY 1, SUITE 600, PALM BEACH GARDENS FL 33408
William M Moore	director